ERBB2 and ductal breast carcinoma in situ: Our incidence rate of DCIS was in the same range as reported by others who also evaluated the presence of adjacent DCIS in pre-NST biopsies, i.e., 37–46% in HER2-positive IBC [14, 24, 25].